Drug intelligence / Profile preview

bupivacaine + saline (Bispebjerg and Frederiksberg Hospital)

Development stage
Unknown
Lead developer
Bispebjerg and Frederiksberg Hospital
Modality
Small Molecules
Administration
Paratendinous Injection
01

Overview

High volume injection (HVI) without corticosteroid is a procedural intervention developed and studied at Bispebjerg Hospital for the treatment of chronic midportion Achilles tendinopathy. The injection consists of a 50 mL solution containing 10 mL of 0.5% bupivacaine hydrochloride (a local anesthetic) and 40 mL of normal saline. Administered under ultrasound guidance into the space between the Achilles tendon and Kager's fat pad, the treatment aims to alleviate pain and improve function through a mechanical 'volume effect.' This effect is hypothesized to physically strip away neovascularization and disrupt the associated nerve ingrowth that contributes to chronic tendon pain, rather than relying on a molecular pharmacological target. It is typically used in conjunction with eccentric exercise therapy.

Other names
High volume injection without corticosteroidHVI without steroidhigh volume injection without corticosteroid-Bispebjerg Hospital-Achilles tendinopathy
02

Targets

SCN5A (Sodium channel protein type 5 subunit alpha)

Beyond the preview

Go deeper on bupivacaine + saline (Bispebjerg and Frederiksberg Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + saline (Bispebjerg and Frederiksberg Hospital).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call